Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
life sciences
national blog main
san francisco blog main
5
×
san francisco top stories
boston blog main
cancer diagnostics
deals
medical device
raleigh-durham blog main
san francisco
boston top stories
cancer
clinical trials
freenome
grail
liquid biopsy
new york blog main
san diego blog main
seattle blog main
startups
thrive earlier detection
10x genomics
abbvie
actavalon
acute myeloid leukemia
aileron therapeutics
aprea therapeutics
arimoclomol
arnold levine
arrowmark partners
astellas pharma
baker brothers
becton dickinson
beta bionics
bigfoot biomedical
biotech ipos
boehringer ingelheim
boston
boston university
What
tests
5
×
blood
company
developing
cancer
deal
expand
medical
treatment
ability
acquire
adding
aims
announced
area
array
babies
based
bay
beta
bio
bionics
biopsy
broader
buildout
business
close
closed
cost
decisions
detect
device
diabetes
diagnostic
diagnostics
driven
files
firm
firms
fold
Language
unset
Current search:
tests
×
" san francisco blog main "
×
@xconomy.com
3 years ago
Grail Files to Go Public; 5 More Life Science Firms Join the IPO Queue
@xconomy.com
4 years ago
Veracyte Aims to Expand Diagnostics Reach With $50M NanoString Deal
@xconomy.com
4 years ago
Liquid Biopsy Firm Lucence Plans Bay Area Buildout With $20M in Tow
@xconomy.com
4 years ago
Invitae Offers $55M for Singular Bio to Expand Prenatal Test Business
@xconomy.com
5 years ago
Beta Bionics Secures $63M as AI-Driven “Pancreas” Heads to Key Tests